Liquidia Corporation Common Stock vs Rollins Inc. Common Stock — how do they compare? Liquidia Corporation Common Stock trades at $33.78 (market cap $2.40B), while Rollins Inc. Common Stock trades at $32.61 (market cap $15.47B). The key difference: Rollins Inc. Common Stock is far larger — about 6.4× Liquidia Corporation Common Stock's market cap, and Rollins Inc. Common Stock pays a 2.27% dividend while Liquidia Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Rollins Inc. Common Stock for 0 Days on average.
| LQDA | ROL | |
|---|---|---|
Market Cap | $2.40B | $15.47B |
Volume | 2,857,547 | 6,712,154 |
Sector | Health | Industrials |
52-Week High | $91.03 | $65.60 |
52-Week Low | $22.02 | $29.69 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $2.30B | $16.48B |
Dividend Yield | — | 2.27% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →Rollins Inc. provides pest control services to residential and commercial customers through its family of brands, including Orkin, across dozens of countries.
Read more on ROL →